Sign In to Follow Application
View All Documents & Correspondence

A Composition Comprising Of At Least One Micro Rna Or Analog Thereof And Uses Thereof

Abstract: The present disclosure provides a composition for cosmetically inhibiting skin pigmentation, said composition comprising of at least one microRNA or analog thereof. Also provided are microRNAs for use in cosmetically inhibiting skin pigmentation.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
20 April 2015
Publication Number
44/2016
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
lsmds@lakshmisri.com
Parent Application
Patent Number
Legal Status
Grant Date
2024-01-08
Renewal Date

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058, India

Inventors

1. MUTHAIYAH, Balu
ITC-LIFE SCIENCES AND TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058, India.
2. SRINIVASAN, Yuvaraj
ITC-LIFE SCIENCES AND TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058, India
3. SINHA, Ranjana
ITC-LIFE SCIENCES AND TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058, India
4. BANDYOPADHYAY, Balaji
ITC-LIFE SCIENCES AND TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058, India

Specification

CLIAMS:1. A composition comprising of at least one microRNA or analog thereof selected from the group consisting of miR23a-3p, miR25a, miR29a and combinations thereof, wherein said composition cosmetically inhibits skin pigmentation.
2. The composition as claimed in claim 1, wherein said at least one microRNA is in mature form, or precursor form.
3. The composition as claimed in any of the claims 1-2, wherein said at least one microRNA is selected from the group consisting of miR23a-3p, miR25a, miR29a, and combinations thereof.
4. The composition as claimed in any of the claims 1-3, wherein said at least one microRNA or analog thereof concentration in said composition is 5-50pmoles.
5. The composition as claimed in any of the claims 1-4, optionally further comprising of suitable carriers, diluents, and excipients.
6. A microRNA or analog thereof for cosmetic inhibition of skin pigmentation, said microRNA selected from the group consisting of miR23a-3p, miR25a, miR29a, and combinations thereof.
7. The microRNA or analog thereof as claimed in claim 6, wherein said microRNA is in mature form, or precursor form.
8. A method for cosmetic inhibition of skin pigmentation, said method comprising of:
a. obtaining a composition as claimed in any of the claims 1-5, or a microRNA or analog thereof as claimed in any of the claims 6-7; and
b. contacting said composition or microRNA with skin,
wherein said method cosmetically inhibits skin pigmentation.

9. Use of a microRNA or analog thereof as claimed in any of the claims 7-8, or a composition as claimed in any of the claims 1-5 in cosmetic inhibition of skin pigmentation.
,TagSPECI:As Attached

Documents

Application Documents

# Name Date
1 2025-CHE-2015-IntimationOfGrant08-01-2024.pdf 2024-01-08
1 PD015758IN-SC SPEC FOR FILING.pdf 2015-04-21
2 PD015758IN-SC Sequence listing.txt 2015-04-21
2 2025-CHE-2015-PatentCertificate08-01-2024.pdf 2024-01-08
3 PD015758IN-SC FORM 5.pdf 2015-04-21
3 2025-CHE-2015-Written submissions and relevant documents [03-01-2024(online)].pdf 2024-01-03
4 PD015758IN-SC FORM 3.pdf 2015-04-21
4 2025-CHE-2015-FORM-26 [19-12-2023(online)].pdf 2023-12-19
5 PD015758IN-SC FIGURES FOR FILING.pdf 2015-04-21
5 2025-CHE-2015-Correspondence to notify the Controller [15-12-2023(online)].pdf 2023-12-15
6 2025-CHE-2015-US(14)-HearingNotice-(HearingDate-20-12-2023).pdf 2023-12-06
6 2025-CHE-2015-FORM 18 [04-03-2019(online)].pdf 2019-03-04
7 2025-CHE-2015-Response to office action [28-09-2021(online)].pdf 2021-09-28
7 2025-CHE-2015-Response to office action [01-09-2022(online)].pdf 2022-09-01
8 2025-CHE-2015-FER.pdf 2021-10-17
9 2025-CHE-2015-Response to office action [28-09-2021(online)].pdf 2021-09-28
9 2025-CHE-2015-Response to office action [01-09-2022(online)].pdf 2022-09-01
10 2025-CHE-2015-FORM 18 [04-03-2019(online)].pdf 2019-03-04
10 2025-CHE-2015-US(14)-HearingNotice-(HearingDate-20-12-2023).pdf 2023-12-06
11 PD015758IN-SC FIGURES FOR FILING.pdf 2015-04-21
11 2025-CHE-2015-Correspondence to notify the Controller [15-12-2023(online)].pdf 2023-12-15
12 PD015758IN-SC FORM 3.pdf 2015-04-21
12 2025-CHE-2015-FORM-26 [19-12-2023(online)].pdf 2023-12-19
13 PD015758IN-SC FORM 5.pdf 2015-04-21
13 2025-CHE-2015-Written submissions and relevant documents [03-01-2024(online)].pdf 2024-01-03
14 PD015758IN-SC Sequence listing.txt 2015-04-21
14 2025-CHE-2015-PatentCertificate08-01-2024.pdf 2024-01-08
15 PD015758IN-SC SPEC FOR FILING.pdf 2015-04-21
15 2025-CHE-2015-IntimationOfGrant08-01-2024.pdf 2024-01-08

Search Strategy

1 SearchstrategyE_20-10-2020.pdf

ERegister / Renewals

3rd: 08 Apr 2024

From 20/04/2017 - To 20/04/2018

4th: 08 Apr 2024

From 20/04/2018 - To 20/04/2019

5th: 08 Apr 2024

From 20/04/2019 - To 20/04/2020

6th: 08 Apr 2024

From 20/04/2020 - To 20/04/2021

7th: 08 Apr 2024

From 20/04/2021 - To 20/04/2022

8th: 08 Apr 2024

From 20/04/2022 - To 20/04/2023

9th: 08 Apr 2024

From 20/04/2023 - To 20/04/2024

10th: 08 Apr 2024

From 20/04/2024 - To 20/04/2025

11th: 13 Mar 2025

From 20/04/2025 - To 20/04/2026